Myriad Genetics Inc (MYGN)
17.60
-0.24
(-1.32%)
USD |
NASDAQ |
Nov 05, 16:00
17.50
-0.10
(-0.54%)
After-Hours: 18:24
Myriad Genetics Total Assets (Quarterly): 1.085B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.085B |
| March 31, 2024 | 1.110B |
| December 31, 2023 | 1.146B |
| September 30, 2023 | 1.149B |
| June 30, 2023 | 1.187B |
| March 31, 2023 | 1.169B |
| December 31, 2022 | 1.199B |
| September 30, 2022 | 1.212B |
| June 30, 2022 | 1.210B |
| March 31, 2022 | 1.255B |
| December 31, 2021 | 1.321B |
| September 30, 2021 | 1.336B |
| June 30, 2021 | 1.360B |
| March 31, 2021 | 1.337B |
| September 30, 2020 | 1.444B |
| June 30, 2020 | 1.405B |
| March 31, 2020 | 1.447B |
| December 31, 2019 | 1.578B |
| September 30, 2019 | 1.591B |
| June 30, 2019 | 1.563B |
| March 31, 2019 | 1.557B |
| December 31, 2018 | 1.557B |
| September 30, 2018 | 1.574B |
| June 30, 2018 | 1.175B |
| March 31, 2018 | 1.218B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.228B |
| September 30, 2017 | 1.228B |
| June 30, 2017 | 1.209B |
| March 31, 2017 | 1.268B |
| December 31, 2016 | 1.276B |
| September 30, 2016 | 1.271B |
| June 30, 2016 | 880.50M |
| March 31, 2016 | 868.20M |
| December 31, 2015 | 871.70M |
| September 30, 2015 | 787.00M |
| June 30, 2015 | 766.20M |
| March 31, 2015 | 779.05M |
| December 31, 2014 | 781.85M |
| September 30, 2014 | 809.01M |
| June 30, 2014 | 823.80M |
| March 31, 2014 | 816.43M |
| December 31, 2013 | 756.68M |
| September 30, 2013 | 781.66M |
| June 30, 2013 | 803.82M |
| March 31, 2013 | 729.03M |
| December 31, 2012 | 717.75M |
| September 30, 2012 | 703.06M |
| June 30, 2012 | 690.64M |
| March 31, 2012 | 699.25M |
| December 31, 2011 | 661.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.085B
Minimum
Jun 2024
1.578B
Maximum
Dec 2019
1.275B
Average
1.234B
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| Abbott Laboratories | 74.36B |
| Personalis Inc | 185.50M |
| Perspective Therapeutics Inc | 385.92M |
| Electromed Inc | 52.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 344.60M |
| Shareholders Equity (Quarterly) | 740.50M |
| Debt to Equity Ratio | 0.0524 |
| Current Ratio | 1.958 |
| Net Debt Paydown Yield | -0.35% |